What Are GLP-1 Receptor Agonists?
GLP-1 receptor agonists are a class of injectable medications that mimic glucagon-like peptide-1 (GLP-1), a hormone your body naturally produces. Originally developed to treat type 2 diabetes, these medications have become powerful weight-loss tools because of how they interact with your appetite, blood sugar, and metabolism.
Common GLP-1 medications include:
- Ozempic (semaglutide) — for diabetes; weight-loss version is Wegovy
- Mounjaro (tirzepatide) — a newer dual-hormone medication (GLP-1 + GIP)
- Saxenda (liraglutide) — an older GLP-1, taken by daily injection
- Victoza (liraglutide) — diabetes formulation
The weight-loss versions (Wegovy, Mounjaro for weight management) are prescribed off-label in Ireland through specialist weight-loss clinics, and increasingly by GPs with appropriate training.
Why GLP-1 Works When Diet and Exercise Alone Don't
Most people with obesity have altered hunger hormones and reward pathways — their brains don't receive "I'm full" signals the way lean individuals' do. This isn't a willpower problem; it's physiology.
GLP-1 drugs reset those pathways. They:
- Reduce cravings for high-calorie foods
- Make portion control feel natural rather than forced
- Decrease the psychological reward from eating
- Prevent the metabolic adaptation (slowdown) that often happens on restrictive diets
This is why patients often report that eating less on GLP-1 "doesn't feel like dieting" — the medication aligns your biology with your goals.
What to Expect: Timeline and Results
GLP-1 results are individual, but here's a realistic roadmap:
- Week 1–2: Reduced appetite, mild nausea (usually fades within 3–5 days)
- Week 2–4: Noticeable weight loss (typically 1–2 kg as water + glycogen depletion)
- Week 4–8: Fat loss accelerates as you naturally eat less; steady 0.5–1 kg/week
- Month 3–6: Appetite suppression deepens, cravings diminish; 5–10 kg loss typical
- Month 6–12: Continued steady loss; by 12 months, 10–15 kg is achievable with compliance
- Ongoing: Weight loss plateau usually occurs at 15–25% body weight reduction (genetics vary)
The drug's effect builds gradually during titration and plateaus after 8–12 weeks on your maintenance dose.
Common Side Effects and How to Manage Them
Most side effects are mild and temporary, especially during titration. The most common:
- Nausea (70% of users in first weeks): Eat smaller meals, avoid fatty/greasy foods, stay hydrated. Usually resolves in 3–7 days.
- Constipation: Increase fibre and water intake; mild laxatives help. Occurs as you eat less overall.
- Fatigue: Often reflects insufficient calorie/protein intake. Ensure 100–130 g protein daily and adequate calories.
- Dizziness: Rare; may indicate dehydration or low blood sugar (if also diabetic).
- Appetite suppression too strong: If you're eating <1,000 kcal/day, ask your doctor about dose reduction.
Serious but rare: Pancreatitis, thyroid concerns (if family history), gallstones (with rapid weight loss). Your clinic monitors for these during check-ins.
Who Is a Good Candidate for GLP-1?
GLP-1 injections are appropriate for:
- Adults aged 18–70+ with BMI ≥27–30 (with comorbidities like hypertension, sleep apnoea, or PCOS) or BMI ≥30+
- People who've tried lifestyle changes and need additional support
- Those with type 2 diabetes seeking dual diabetes + weight-loss control
- Individuals committed to ongoing monitoring and diet/lifestyle support alongside the medication
Not suitable:
- Type 1 diabetes patients (unless specifically indicated by their endocrinologist)
- Pregnant or breastfeeding women
- History of medullary thyroid cancer or multiple endocrine neoplasia (MEN) syndrome
- Severe kidney or liver disease (relative contraindication; discuss with your doctor)
- Those unable to commit to regular injections or medical follow-up
Cost and Access in Ireland
GLP-1 medications are not routinely covered by the Irish HSE for weight loss (only for diabetes). Private costs range from €150–300/month depending on the medication and clinic. Slimbr clinics work with you on transparent pricing and payment plans.
Many patients find the cost justified by the results and avoided complications (heart disease, joint stress, etc.), but it's a long-term investment. Some private health insurance schemes cover a portion; check your policy.
The Bottom Line
GLP-1 injections work by aligning your body's appetite and satiety signals with your weight-loss goals. They're not magic — you still need to eat better and move — but they make that easier by removing the biological fight against hunger that makes traditional dieting so hard.
If you've tried diet and exercise and want medical support, GLP-1 is a proven, well-tolerated option with strong trial evidence. The key is choosing a clinic that monitors you, adjusts your dose, and supports your long-term health.
